pharma · postmenopausal women with vasomotor menopausal symptoms
Estetra
Estetra SPRL
Estetra SPRL is a pharma organization headquartered in EU. Primary therapeutic focus areas include postmenopausal women with vasomotor menopausal symptoms. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), a
Company details
- Status
- Public
- HQ
- Liège, BE
- Employees
- 30
- Programs
- 1
- Drugs
- 6
- Patents
- 0
Quick answer
Estetra SPRL is a pharma organization headquartered in EU. Primary therapeutic focus areas include postmenopausal women with vasomotor menopausal symptoms. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 2 (1).
Company snapshot
ESTETRA is a pharmaceuticals company based out of 5 Rue Saint-Georges, Liège, Belgium.
- 1 active pipeline program(s) linked via ClinicalTrials.gov.
- 1 trial update(s) in the last 12 months.
Public regulatory, clinical, patent, and corporate records for Estetra. Not investment advice.
Top assets
Lead pipeline drugs
- Marketed / approved
- Marketed / approved
- Marketed / approved
- Marketed / approved
Active clinical programs
- Phase 2
Momentum signals
Momentum
Proprietary activity score for Estetra.
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Competitive landscape
Recent activity
Recent activity
Latest pipeline, patent, and corporate events for Estetra.
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is Estetra?
-
Is Estetra publicly traded?
-
What drugs does Estetra develop or market?
-
What are the latest developments for Estetra?
-
What therapeutic areas does Estetra focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.